KCNH2 and breast carcinoma: Indeed, scDb-hERG1-β1-TRAIL exerts proapoptotic, antiproliferative effects in breast cancer cells, mainly TNBC, which express the hERG1/β1 integrin complex and are TRAIL-sensitive, cultured in vitro either in classic 2D or 3D cultures within a microfluidic chip.